Parameter
| Biomarker | PAG | Full name | Phenylacetylglutamine | Molecular Type | Metabolite |
|---|---|---|---|---|---|
| Molecular Formula | C11H14N2O3 | Molecular Weight | 222.24 g/mol | Core Functional Dimensions | Pathological Confirmation |
| Disease | Parkinson's Disease | Disease Subtypes | / | ||
| Organ | Brain | Test Sample / Technology Platform | Plasma (LC-MS, GC-MS) | ||
| Pathobiological Mechanisms | Abnormal amino acid metabolism, involved in PD neurotoxic pathways. | ||||
| Clinical Availability Status | Research exploration: Plasma levels are elevated in PD patients. | ||||
| Notes and Dynamics | Positively correlated with the degree of PD cognitive impairment. | ||||